Santseharay Ramírez
- Hepatology top 0.5%
- Hepatitis C virus research 36
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research 20
- COVID-19 Clinical Research Studies 10
- SARS-CoV-2 detection and testing 7
- HIV/AIDS drug development and treatment 6
- Epidemiology top 5%
- Hepatitis B Virus Studies 28
- Liver Disease Diagnosis and Treatment 19
- Nephrology top 5%
- Virology top 10%
-
- Monoclonal and Polyclonal Antibodies Research 8
Santseharay Ramírez
56 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 80
- Hepatology 1.0k
- Infectious Diseases 545
- Epidemiology 960
- Nephrology 104
- Virology 65
Countries citing papers authored by Santseharay Ramírez
This map shows the geographic impact of Santseharay Ramírez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Santseharay Ramírez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Santseharay Ramírez more than expected).
Fields of papers citing papers by Santseharay Ramírez
This network shows the impact of papers produced by Santseharay Ramírez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Santseharay Ramírez. The network helps show where Santseharay Ramírez may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Santseharay Ramírez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 7 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 10 | |
| 7 | Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture systembreakdown → | 2022 | 132 |
| 8 | 2022 | 24 | |
| 9 | 2021 | 24 | |
| 10 | 2021 | 63 | |
| 11 | 2021 | 37 | |
| 12 | 2021 | 9 | |
| 13 | 2020 | 5 | |
| 14 | 2020 | 8 | |
| 15 | 2019 | 8 | |
| 16 | 2018 | 32 | |
| 17 | 2018 | 3 | |
| 18 | 2011 | 18 | |
| 19 | 2009 | 42 | |
| 20 | 2007 | 7 |
About Santseharay Ramírez
Santseharay Ramírez is a scholar working on Hepatology, Infectious Diseases and Epidemiology, having authored 60 papers that have together received 1.7k indexed citations. Recurring topics across this work include Hepatitis C virus research (36 papers), Hepatitis B Virus Studies (28 papers), SARS-CoV-2 and COVID-19 Research (20 papers), Liver Disease Diagnosis and Treatment (19 papers), COVID-19 Clinical Research Studies (10 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), SARS-CoV-2 detection and testing (7 papers) and HIV/AIDS drug development and treatment (6 papers). The work is most often cited by research in Hepatology (1.0k citations), Infectious Diseases (545 citations) and Epidemiology (960 citations). Santseharay Ramírez has collaborated with scholars based in Denmark, Spain and United States. Frequent co-authors include Jens Bukh, Judith M. Gottwein, Yi‐Ping Li, Lotte S. Mikkelsen, Ulrik Fahnøe, Sanne B. Jensen, Long V. Pham, Xavier Forns, Sofía Pérez‐del‐Pulgar and Troels K. H. Scheel. Their work appears in journals such as Proceedings of the National Academy of Sciences, Gastroenterology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.